Nadeau JH - Search Results

1

Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry.

Daniel VC, Minton TA, Brown NJ, Nadeau JH, Morrow JD. Daniel VC, et al. Among authors: nadeau jh. J Chromatogr B Biomed Appl. 1994 Mar 4;653(2):117-22. doi: 10.1016/0378-4347(93)e0432-p. J Chromatogr B Biomed Appl. 1994. PMID: 8205238

2

Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.

Brown NJ, Ryder D, Gainer JV, Morrow JD, Nadeau J. Brown NJ, et al. J Pharmacol Exp Ther. 1996 Nov;279(2):703-12. J Pharmacol Exp Ther. 1996. PMID: 8930174 Clinical Trial.

3

Caffeine attenuates the renal vascular response to angiotensin II infusion.

Brown NJ, Ryder D, Nadeau J. Brown NJ, et al. Hypertension. 1993 Dec;22(6):847-52. doi: 10.1161/01.hyp.22.6.847. Hypertension. 1993. PMID: 8244516

4

Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.

Brown NJ, Nadeau JH, Vaughan DE. Brown NJ, et al. Among authors: nadeau jh. Thromb Haemost. 1997 Mar;77(3):522-5. Thromb Haemost. 1997. PMID: 9066005 Clinical Trial.

5

Increased sensitivity to bradykinin among African Americans.

Gainer JV, Nadeau JH, Ryder D, Brown NJ. Gainer JV, et al. Among authors: nadeau jh. J Allergy Clin Immunol. 1996 Aug;98(2):283-7. doi: 10.1016/s0091-6749(96)70151-3. J Allergy Clin Immunol. 1996. PMID: 8757204 Clinical Trial.

6

Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant.

Gainer JV, Hunley TE, Kon V, Nadeau JH, Muldowney JA 3rd, Brown NJ. Gainer JV, et al. Among authors: nadeau jh. Biochem Mol Biol Int. 1997 Sep;43(1):227-31. doi: 10.1080/15216549700204001. Biochem Mol Biol Int. 1997. PMID: 9315301

7

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.

Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE. Brown NJ, et al. Among authors: nadeau jh. J Clin Endocrinol Metab. 2000 Jan;85(1):336-44. doi: 10.1210/jcem.85.1.6305. J Clin Endocrinol Metab. 2000. PMID: 10634408 Clinical Trial.

8

Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.

Byrd JB, Touzin K, Sile S, Gainer JV, Yu C, Nadeau J, Adam A, Brown NJ. Byrd JB, et al. Hypertension. 2008 Jan;51(1):141-7. doi: 10.1161/HYPERTENSIONAHA.107.096552. Epub 2007 Nov 19. Hypertension. 2008. PMID: 18025295 Free PMC article.

9

Clinical experience over 48 years with pheochromocytoma.

Goldstein RE, O'Neill JA Jr, Holcomb GW 3rd, Morgan WM 3rd, Neblett WW 3rd, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN, Scott HW Jr. Goldstein RE, et al. Ann Surg. 1999 Jun;229(6):755-64; discussion 764-6. doi: 10.1097/00000658-199906000-00001. Ann Surg. 1999. PMID: 10363888 Free PMC article.

10

Does race predispose to angiotensin-associated angioneurotic edema?

Brown NJ, Nadeau JH. Brown NJ, et al. Among authors: nadeau jh. Ann Intern Med. 1993 Dec 15;119(12):1224. doi: 10.7326/0003-4819-119-12-199312150-00020. Ann Intern Med. 1993. PMID: 8239260 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page